Clinical Trials Logo

Filter by:
NCT ID: NCT04675034 Completed - Clinical trials for Painful Osteoarthritis of the Knee

A Study of the Efficacy and Safety of MEDI7352 in Subjects With Painful Osteoarthritis of the Knee

BESPOKE
Start date: December 2, 2020
Phase: Phase 2
Study type: Interventional

This is a Phase 2b randomised, double-blind, placebo-controlled, dose-response study in subjects with painful osteoarthritis (OA) of the knee. The study will assess the safety and efficacy of multiple doses of MEDI7352 compared to placebo, as well as the pharmacokinetics, pharmacodynamics and immunogenicity of MEDI7352 in subjects with moderate to severe chronic pain persistent for 3 months or more not adequately controlled by standard of care treatments.

NCT ID: NCT04672993 Completed - Clinical trials for Urinary Incontinence

Exploratory Study of a New Urine Collection Device for Men

Start date: November 2, 2020
Phase: N/A
Study type: Interventional

The aim of the investigation is to evaluate the subjects experience of a new collection device for men. An open-labelled, single arm study design was chosen for this investigation with a duration of 1 week + up to 3 days extra.

NCT ID: NCT04672382 Completed - Morphine Clinical Trials

Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to the effect of opioid (morphine) intradermal application on histaminergic and non-histaminergic itch. In particular, we would like to demonstrate that also peripheral administration of morphine may affect mast cell release of histamine.

NCT ID: NCT04669951 Completed - Clinical trials for Esophagus Cancer, Adenocarcinoma

Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer

Start date: November 18, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to investigate urokinase Plasminogen Activator Receptor (uPAR) microexpression in gastroesophageal cancer (adenocarcinomas) both qualitatively and semi-quantitatively and to evaluate if it offers a possibility for future imagining purposes.

NCT ID: NCT04669418 Completed - Infection Clinical Trials

Host RNA Signature in Children With Cancer and Infection

Start date: June 1, 2019
Phase:
Study type: Observational

The aim is to investigate if RNA expression signature can discriminate bacterial from viral infection or non-infectious inflammation in children with cancer. Earlier studies in immunocompetent children have shown promising results, but studies in immunocompromised children are lacking. We aim to include 300 febrile episodes in children with cancer. The samples will be analysed by RNA sequencing. If succesfull, this method can help prevent unnecessary antibiotic treatment, reduce hospital admissions, side effects and antimicrobial resistance and improve quality of life for children during cancer treatment.

NCT ID: NCT04667195 Completed - Clinical trials for Acute Pyelonephritis

Clinical Characteristics of Acutely Hospitalized Adults With Acute Pyelonephritis

Start date: March 1, 2021
Phase:
Study type: Observational

Acute pyelonephritis is an acute infection. Today the diagnosis is made primarily on the basis of unspecific clinical symptoms with flank tenderness combined with as a key clue. This study will investigate which clinical and paraclinical characteristics available within 4 hours of hospital stay, that describes the patients admitted in the emergency department with acute pyelonephritis the best.

NCT ID: NCT04666207 Completed - Covid19 Clinical Trials

Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19

Start date: May 25, 2020
Phase:
Study type: Observational

Data on COVID-19 in children are still scarce, and their role in SARS-CoV-2 transmission is poorly described. Furthermore, documentation of the best SARS-CoV-2 sampling methods in children are limited. In adults, saliva seems like a promising specimen to collect by noninvasive procedure to diagnose and monitor viral load of SARS-CoV-2, but this has not been tested in children yet. We want to test the following hypothesis: 1. Shedding load and duration of SARS-CoV-2 in children are related to age, gender, clinical symptoms and exposure 2. Salvia samples have equal or higher sensibility than nasal swaps in children for detection of SARS-CoV-2 3. Parental home testing of saliva and feces is feasible in children The study is a prospective cohort study of SARS-CoV-2 PCR-positive children from two test centers in the Capital Region of Denmark. Children aged 0-17 years with a PCR-positive SARS-CoV-2 test from a nasal or pharyngeal swab is included from May 2020 to January 2021 and followed-up for a period of 28 days with weekly sample collection and questionnaires. Samples include a saliva sample, a nasal swap and a rectal swap for children under four years of age. A semiquantitative RT-PCR method, will identify positive and negative samples and provide a Ct value estimating viral load. Saliva and fecal samples will be analyzed from November 2020-February 2021. Shedding duration will be related to medial history, clinical presentation, exposure, gender and age.

NCT ID: NCT04663074 Completed - Clinical trials for Thoracic Aortic Aneurysm

Intravascular Ultrasound (IVUS) in Complex Aortic Endovascular Interventions

Start date: May 22, 2020
Phase:
Study type: Observational [Patient Registry]

The study aims to investigate the applicability of intravascular ultrasound (IVUS) in the endovascular therapy of juxta-, supra- and thoracoabdominal aortic aneurysms. The focus of the study is on the intraoperative and postoperative evaluation of the geometric data of bridging stentgrafts in terms of patency, occurrence of stenosis and/or kinking.

NCT ID: NCT04661085 Completed - Infection Clinical Trials

Infection With Unknown Origin in the Emergency Department

Start date: March 1, 2021
Phase:
Study type: Observational

Patients suspected with infection is one of the major groups, who are admitted to the Danish Emergency Departments (ED). Currently, there is no overall description of the distribution of these infections. The aim of this study is to characterize ED patients with a suspected infection whereby the focus of the infection is of an unknown origin.

NCT ID: NCT04660279 Completed - Clinical trials for Positron-Emission Tomography

Dynamic FDG PET/CT: Optimization and Validation of Data Acquisition

VALIDATE
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Quantification of the metabolic rate of glucose from Dynamic Whole-Body PET examinations requires measurements of the time course of the radioactivity concentrations in arterial blood by blood sampling, and in the tissue of interest by dynamic PET. Invasive arterial blood sampling cannot be part of a standard examination, and therefore the blood samples need to be replaced by activity concentrations derived from the PET images, usually from small volumes in the descending aorta or left ventricle. Newly developed scanner software (Siemens) allows automated CT-based identification of blood pool regions and extraction of an image-derived blood input function from the corresponding PET data. However, this automated method needs validation, as it could be prone to systematic errors caused by limited spatial resolution, patient movement, and image reconstruction. We will use invasively measured arterial blood samples as a reference for validation of methods to extract non-invasive PET image-derived input functions and quantify any systematic errors that could propagate to the resulting parametric images.